Kidney Cancer


Kidney cancer, also known as renal cell carcinoma (RCC), is a type of cancer that originates in the cells of the kidneys. The kidneys are vital organs responsible for filtering blood, removing waste products, and regulating fluid and electrolyte balance in the body. Kidney cancer is one of the most common types of cancer that affects the urinary system.


The most common type of kidney cancer is renal cell carcinoma (RCC), which has several subtypes based on the appearance of the cancer cells under a microscope. Clear cell RCC is the most prevalent subtype. There are also less common types, including papillary RCC and chromophobe RCC.

Risk Factors

Several factors can increase the risk of developing kidney cancer, including:

  • Age: The risk increases with age.
  • Smoking: Cigarette smoking is a significant risk factor.
  • Obesity: Excess body weight is associated with an increased risk.
  • High blood pressure: Hypertension is a risk factor for kidney cancer.
  • Occupational exposure: Certain occupational exposures to chemicals and toxins may increase risk.
  • Family history: A family history of kidney cancer or certain genetic conditions (such as von Hippel-Lindau disease) can elevate the risk.


Kidney cancer often doesn’t cause symptoms in its early stages. As the tumor grows, common symptoms might include:

  • Blood in the urine (hematuria)
  • Pain or discomfort in the side or back
  • A mass or lump in the abdomen
  • Unexplained weight loss
  • Fatigue
  • Fever


Diagnosis of kidney cancer typically involves a combination of imaging tests, such as CT scans, MRI, and ultrasound, to visualize the tumor and assess its characteristics. A biopsy might be performed to confirm the diagnosis and determine the cancer type.


Staging helps determine the extent of cancer spread. Kidney cancer is staged based on the size of the tumor, its invasion into nearby tissues, and whether it has spread to lymph nodes or other organs.


Treatment options for kidney cancer depend on the stage of the cancer, the patient’s overall health, and other factors. Common treatment approaches include:

  • Surgery: Surgical removal of the tumor (nephrectomy) is the primary treatment for localized kidney cancer. In some cases, partial nephrectomy (removal of the tumor while preserving healthy kidney tissue) might be an option.
  • Targeted Therapies: Medications that target specific molecules involved in cancer growth may be used for advanced or metastatic kidney cancer.
  • Immunotherapy: Immune checkpoint inhibitors are a type of immunotherapy that help the immune system recognize and attack cancer cells.
  • Radiation Therapy: Radiation therapy might be used in specific cases, such as when surgery is not possible or to relieve symptoms.


The prognosis for kidney cancer varies based on the stage at diagnosis. Early-stage kidney cancer is generally associated with a better prognosis. Advanced or metastatic kidney cancer is more challenging to treat but can still respond to targeted therapies and immunotherapy.

If you suspect you might have kidney cancer or are concerned about your kidney health, it’s important to consult a medical professional. A urologist or an oncologist with expertise in kidney cancer can provide accurate diagnosis, staging, and guidance on treatment options tailored to your specific situation.

Accredited By